ç§åŠæè¡æ¯èæ©æ§(JST)ãšæ±äº¬å€§åŠã¯7æ22æ¥ãæ±æµ·å€§åŠã京éœå€§åŠãéæ²¢å€§åŠãšã®å ±åç ç©¶ã«ããããèºç·ç¶çãããããããæŽ»æ§åç·ç¶èœçްèããç å€éšäœã«éç©ããã¡ã«ããºã ã®äžç«¯ãæããã«ãããšå ±åã§çºè¡šããã
ææã¯ãæ±å€§å»åŠç³»ç ç©¶ç§ã®æŽ¥ä¹ äºéåæ°(æ¥æ¬åŠè¡æ¯èäŒç¹å¥ç ç©¶å¡)ãåã»äžçŸœæå²è¬åž«ãåã»æŸå³¶ç¶±æ²»ææãæ±æµ·å€§ã®çš²å£è±ææãäº¬å€§ã®æžæé倫忿ãéæ²¢å€§ã®æ©æ¬çäžç¹ä»»ææãã®å ±åç ç©¶ããŒã ã«ãããã®ãç ç©¶ã¯JST課é¡éæååºç€ç ç©¶ã®äžç°ãšããŠè¡ããããã®ã§ã詳现ãªå 容ã¯ãç±³åœæ±éšæé7æ22æ¥ä»ãã§åœç§åŠèªãThe American Journal of Pathologyãã®ãªã³ã©ã€ã³éå ±çã«æ²èŒãããã
ãèåšç·ç¶åãã¯æ ¢æ§ççç¶æ ã«ããèåšã«ãããŠããIåã³ã©ãŒã²ã³ããªã©ã®è åç·ç¶ãäžå¯éçã«æ²çããåçãäžå¯èœã«ãªãçŸæ£ã®ããšããããèåšã®æ©èœãæ ãäžç®çµç¹ãIåã³ã©ãŒã²ã³ãå«ãã现èå€ãããªãã¯ã¹ãã«çœ®ãæãã£ãŠããŸãã®ã ã现èå€ãããªãã¯ã¹ãšã¯ãçµç¹ã®çްèå€é åã«ååšããçµç¹ã®æ§é ãä¿ã£ããã现èã®è¶³å ŽãæäŸãã圹å²ãæãããããããšããããçµåçµç¹ãæ§æããäž»ãªååã§ãããã现èå€ãããªãã¯ã¹ãæ§æããäž»ãªååãšããŠã¯ã³ã©ãŒã²ã³ãããã©ã³ç¡«é žããã¢ã«ãã³é žãªã©ãã¢ã³ããšã€ãžã³ã°ã§è³ã«ããååãå€ãã¯ãã ã
ããããèåšç·ç¶åãé²è¡ãããšæçµçã«ã¯èåšäžå šã«è³ã£ãŠããŸãã代衚çãªç·ç¶åçŸæ£ãšããŠãèèãç¹ç¶åãããè硬å€ããªã©ãããããã®æ£è æ°ã¯çŽ40äžäººã«ããã¶ãããã«ããç³å°¿ç æ§è çãã«ããéæãåããŠããæ£è ãçŽ10äžäººã«ãããã§ãããèºã®ç·ç¶åçŸæ£ã®ããã«ãäžã«ã¯ç·ç¶åã«ããèåšäžå šãæ»ã«çŽçµããŠããŸããã®ãããããç¹çºæ§èºç·ç¶çãã®æ£è æ°ã¯åœå ã«ãããŠã¯1äžäººä»¥äžã ããããã®ç·ç¶åçŸæ£ã«å¯ŸããŠã¯èåšç§»æ€ãé€ããŠæå¹ãªæ²»çæ³ããªããæ²»çè¬ã®éçºã«åããç·ç¶åã®ã¡ã«ããºã è§£æãæ¥ãããŠããã
ç·ç¶åãããããåå ãšããŠã掻æ§åããç·ç¶èœçްèãç·ç¶åéšäœã«éç©ããIåã³ã©ãŒã²ã³ã倧éã«ç£çããããšãè§£ææžã¿ã ãç¹ã«ããα-SMA(α-smooth muscle actin)ããšåŒã°ããå¹³æ»ç现èã«å€ãååšããã¿ã³ãã¯è³ªãçºçŸãããçç·ç¶èœçްèããã现èå€ãããªãã¯ã¹ã¿ã³ãã¯è³ªãé«çºçŸããããšãç¥ãããŠããã
ããããçç·ç¶èœçްèã®èµ·æºãšãªã现èã«é¢ããŠã¯ããŸããŸãªè°è«ãããããã®ååçµè·¯ãäŸçµŠã»ç¶ææ©æ§ã¯äžæãªãŸãŸã§ãããæè¡çã«ããç·ç¶èœçްèã«ã¯ç¹ç°çãªè¡šé¢ããŒã«ãŒååãèŠã€ãã£ãŠããããåå®ãå°é£ã ããŸãåŸæ¥ã®ç·ç¶åç ç©¶ã§äž»ãªç ç©¶ææ³ã§ãã£ãç ççµç¹è§£æã§ã¯ãçŽ°èæ©èœãéºäŒåçºçŸã®å€åãè©äŸ¡ã§ããªãã£ããããç·ç¶åã®éçšã§æŽ»æ§åããç·ç¶èœçްèãã©ã®ããã«ç·ç¶åéšäœãžéç©ããã®ãããã®è©³çްã¯äžæã ã£ãã
ããããäžã§ç ç©¶ããŒã ã¯ä»åãããã¬ãªãã€ã·ã³ã(èºã®ç·ç¶åãšããå¯äœçšãåé¡ãšãªã£ãŠããæããå€ã®1çš®)èªå°æ§ããŠã¹èºç·ç¶çã¢ãã«ã«ãããç·ç¶èœçްèã®éçã»è³ªçå€åãå®éçã«è§£æããããšã«æåããã®ã§ããã
ç·ç¶èœçŽ°èæ°ã®çµæçãªå€åãè§£æãããšããããããŸã§ç·ç¶åéšäœã§å¢å ãããšèããããŠããç·ç¶èœçްèã®èºå šäœã«ãããæ°ã¯ãå®éã«ã¯å¢å ããªãããšãæããã«ãªã£ãããŸããç·ç¶èœçްèã®äžéšã¯Î±-SMAãçºçŸããçç·ç¶èœçްèã«ååããŠããããšã倿ãç·ç¶åã«äŒŽãç·ç¶èœçްèã®å¢æ®ãšçŽ°èæ»ã®é¢ä¿ã調ã¹ãããççã®ããŒã¯æã«ã¯çްè墿®ãšçŽ°èæ»ã¯ã©ã¡ããé«ãŸãããç·ç¶åéšäœã§éç©ããŠããç·ç¶èœçްèã§çްè墿®ã«ããå¢ãã现èã¯ããäžéšã§ãããç·ç¶èœçްèã®éç©ã«çްèç§»åã倧ããé¢äžããŠããå¯èœæ§ãåããŠç€ºãããã®ã§ãã(ç»å1)ã
ãŸããé«åºŠã«çŽåããç·ç¶èœçްèã«ã€ããŠã次äžä»£DNAã·ãŒã¯ãšã³ãµãŒãçšããå æ¬çéºäŒåçºçŸè§£æãè¡ããç·ç¶åã®é²è¡ã«äŒŽãèºç·ç¶èœçްèã§çºçŸå€åãããã¹ãŠã®éºäŒåãæããã«ããããã®çµæã现èå€ãããªãã¯ã¹ã现èåšæã现èç§»åã«é¢ããååã®éºäŒåçºçŸãé«ããªã£ãŠãããç¹ã«çްèå€ãããªãã¯ã¹ã¿ã³ãã¯è³ªã®1çš®ã§ããããªã¹ããªãã³ãã³ãã匷ãèªå°ãããæ°ããªæŽ»æ§åç·ç¶èœçްèããŒã«ãŒãªãã³ã«ç å¢ããŒã«ãŒã«ãªãå¯èœæ§ãèŠåºãããã®ã§ãã(ç»å4)ã
以äžã®çµæãããèºã®ç·ç¶åãé²è¡ããéšäœã§ã¯ãªã¹ããªãã³ãã³ãçºçŸããç·ç¶èœçްèãå€ãååšããç·ç¶åé åã®äžå€®éšã§ã¯Î±-SMAãçºçŸããçç¹ç¶èœçްèã«ååããããšãæããã«ãªã£ãããŸãããªã¹ããªãã³ãã³ãç·ç¶èœçްèã®ç·ç¶åé åãžã®ç§»åãä¿é²ããŠããå¯èœæ§ã瀺åããã圢ã (ç»å6)ã
ç»å6ã¯ããªã¹ããªãã³ãã³éœæ§æŽ»æ§åç·ç¶èœçްèã¯ç·ç¶åã®æåç·ã«éç©ãããšããããšã衚ããæš¡åŒå³ãèå å ç«æè²ã§ãªã¹ããªãã³ãã³ãçºçŸããŠããç·ç¶èœçްèã®èºã«ãããå±åšã調ã¹ããããšãããç·ç¶èœçްèãã¯ã©ã¹ã¿ãŒã圢æããŠããç·ç¶åé åã®æåç·(ãªã¢ããªã³ã°éšäœ)ã«ååšããŠããããšãæãããšãªã£ãããŸãα-SMAãçºçŸããŠããçç·ç¶èœçްèã¯ç·ç¶åé åã®äžå€®éšã«å€ãååšããŠããããã®ããšã¯ãªã¹ããªãã³ãã³éœæ§ç·ç¶èœçްèãç·ç¶åé åã®æ¡å€§ã«ç©æ¥µçãªåœ¹å²ãæãããŠããå¯èœæ§ã瀺ããŠããã
|
|
ç»å6ããªã¹ããªãã³ãã³éœæ§æŽ»æ§åç·ç¶èœçްèã¯ç·ç¶åã®æåç·ã«éç©ãããšããããšã衚ããæš¡åŒå³ |
ä»åæããã«ãªã£ãç·ç¶èœçްèç¹ç°çãªéºäŒåçºçŸãšç·ç¶èœçްèéç©ã®ã¡ã«ããºã ã«åºã¥ããç·ç¶åã®é²è¡ãšäžå¯éæ§ã®ã¡ã«ããºã ã现èãååã¬ãã«ã§æããã«ãããããšã§ãèºç·ç¶çã®æ°ããªèšºæã»äºé²ã»æ²»çæ³ã®éçºã«ã€ãªããããšãæåŸ ããããšããŠããã
